BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35874608)

  • 21. A Novel Computational Model Predicts Key Regulators of Chemokine Gradient Formation in Lymph Nodes and Site-Specific Roles for CCL19 and ACKR4.
    Jafarnejad M; Zawieja DC; Brook BS; Nibbs RJB; Moore JE
    J Immunol; 2017 Oct; 199(7):2291-2304. PubMed ID: 28807994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A key role for CCR7 in establishing central and peripheral tolerance.
    Worbs T; Förster R
    Trends Immunol; 2007 Jun; 28(6):274-80. PubMed ID: 17462953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR7 Sulfotyrosine Enhances CCL21 Binding.
    Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging role of chemokine receptor 7 in atherosclerosis.
    Schieffer B; Luchtefeld M
    Trends Cardiovasc Med; 2011 Nov; 21(8):211-6. PubMed ID: 22902067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
    Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
    J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
    Haessler U; Pisano M; Wu M; Swartz MA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes.
    Heydtmann M; Hardie D; Shields PL; Faint J; Buckley CD; Campbell JJ; Salmon M; Adams DH
    J Immunol; 2006 Jul; 177(1):729-38. PubMed ID: 16785572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor.
    Pesce S; Moretta L; Moretta A; Marcenaro E
    Front Immunol; 2016; 7():414. PubMed ID: 27774094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct Fates of Chemokine and Surrogate Molecule Gradients: Consequences for CCR7-Guided Dendritic Cell Migration.
    Artinger M; Gerken OJ; Purvanov V; Legler DF
    Front Immunol; 2022; 13():913366. PubMed ID: 35769489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions in Viral Infection and Prevention.
    Yan Y; Chen R; Wang X; Hu K; Huang L; Lu M; Hu Q
    Front Cell Dev Biol; 2019; 7():212. PubMed ID: 31632965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
    Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
    J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
    Ebert LM; Schaerli P; Moser B
    Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
    Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses.
    Hauser MA; Kindinger I; Laufer JM; Späte AK; Bucher D; Vanes SL; Krueger WA; Wittmann V; Legler DF
    J Leukoc Biol; 2016 Jun; 99(6):993-1007. PubMed ID: 26819318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCR7/CCL19 controls expression of EDG-1 in T cells.
    Shannon LA; McBurney TM; Wells MA; Roth ME; Calloway PA; Bill CA; Islam S; Vines CM
    J Biol Chem; 2012 Apr; 287(15):11656-64. PubMed ID: 22334704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR7: roles in cancer cell dissemination, migration and metastasis formation.
    Legler DF; Uetz-von Allmen E; Hauser MA
    Int J Biochem Cell Biol; 2014 Sep; 54():78-82. PubMed ID: 25019368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections.
    Unsoeld H; Mueller K; Schleicher U; Bogdan C; Zwirner J; Voehringer D; Pircher H
    Int Immunol; 2007 Nov; 19(11):1281-9. PubMed ID: 17914120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.
    Fevang B; Yndestad A; Damås JK; Halvorsen B; Holm AM; Beiske K; Aukrust P; Frøland SS
    Clin Exp Immunol; 2009 Nov; 158(2):237-45. PubMed ID: 19747210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
    Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
    J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.
    Wiley HE; Gonzalez EB; Maki W; Wu MT; Hwang ST
    J Natl Cancer Inst; 2001 Nov; 93(21):1638-43. PubMed ID: 11698568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.